Clinical Trials Browser

OTHER × Triple Negative Breast Neoplasms × Lymphoid × Clear all

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Lymphoma, B-Cell, Dendritic Cell Sarcoma, Interdigitating, Triple Negative Breast Neoplasms

NCT02706392 2022-08-31

Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies

Phase 1 Terminated

21 enrolled 19 charts

BreastLymphoidOther hematologic neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Leukemia, Lymphocytic, Chronic, B-Cell, Hematologic Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Triple Negative Breast Neoplasms

NCT03291938 2020-11-24

IACS-010759 in Advanced Cancers

Phase 1 Completed

29 enrolled

BreastGastrointestinalLymphoid

Lymphoma, Neoplasm Metastasis, Pancreatic Neoplasms, Triple Negative Breast Neoplasms

NCT02599194 2019-01-03

18F-FSPG PET/CT for Cancer Patients on Therapy

Phase 2 Completed

7 enrolled 6 charts

BreastGenitourinaryLymphoidOther solid neoplasmThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Mesothelioma, Lymphoma, B-Cell, Triple Negative Breast Neoplasms

Clinical Trials

Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study

Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies

IACS-010759 in Advanced Cancers

18F-FSPG PET/CT for Cancer Patients on Therapy